accountOn Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth. Friday is Day One for the combined companies. The mood at the two giant organizations no doubt varies by function and location. But a juxtaposition of two facts in a Bloomberg report suggests the swirl of emotions researchers at the two companies may be feeling.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Doozy of a Day One for Pfizer-Wyeth R&D
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
